Complex interactions among diet, gastrointestinal transit, and gut microbiota in humanized mice
- PMID: 23380084
- PMCID: PMC3890323
- DOI: 10.1053/j.gastro.2013.01.047
Complex interactions among diet, gastrointestinal transit, and gut microbiota in humanized mice
Abstract
Background & aims: Diet has major effects on the intestinal microbiota, but the exact mechanisms that alter complex microbial communities have been difficult to elucidate. In addition to the direct influence that diet exerts on microbes, changes in microbiota composition and function can alter host functions such as gastrointestinal (GI) transit time, which in turn can further affect the microbiota.
Methods: We investigated the relationships among diet, GI motility, and the intestinal microbiota using mice that are germ-free (GF) or humanized (ex-GF mice colonized with human fecal microbiota).
Results: Analysis of gut motility revealed that humanized mice fed a standard polysaccharide-rich diet had faster GI transit and increased colonic contractility compared with GF mice. Humanized mice with faster transit due to administration of polyethylene glycol or a nonfermentable cellulose-based diet had similar changes in gut microbiota composition, indicating that diet can modify GI transit, which then affects the composition of the microbial community. However, altered transit in mice fed a diet of fermentable fructooligosaccharide indicates that diet can change gut microbial function, which can affect GI transit.
Conclusions: Based on studies in humanized mice, diet can affect GI transit through microbiota-dependent or microbiota-independent pathways, depending on the type of dietary change. The effect of the microbiota on transit largely depends on the amount and type (fermentable vs nonfermentable) of polysaccharides present in the diet. These results have implications for disorders that affect GI transit and gut microbial communities, including irritable bowel syndrome and inflammatory bowel disease.
Copyright © 2013 AGA Institute. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Figures
![None](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3890323/bin/nihms439226f1.gif)
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3890323/bin/nihms439226f2.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3890323/bin/nihms439226f3.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3890323/bin/nihms439226f4.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3890323/bin/nihms439226f5.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3890323/bin/nihms439226f6.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3890323/bin/nihms439226f7.gif)
Similar articles
-
Saccharomyces boulardii CNCM I-745 modulates the microbiota-gut-brain axis in a humanized mouse model of Irritable Bowel Syndrome.Neurogastroenterol Motil. 2021 Mar;33(3):e13985. doi: 10.1111/nmo.13985. Epub 2020 Sep 21. Neurogastroenterol Motil. 2021. PMID: 32955166
-
Effect of wheat bran derived prebiotic supplementation on gastrointestinal transit, gut microbiota, and metabolic health: a randomized controlled trial in healthy adults with a slow gut transit.Gut Microbes. 2020 Nov 9;12(1):1704141. doi: 10.1080/19490976.2019.1704141. Epub 2020 Jan 25. Gut Microbes. 2020. PMID: 31983281 Free PMC article. Clinical Trial.
-
Involvement of gut microbiota in association between GLP-1/GLP-1 receptor expression and gastrointestinal motility.Am J Physiol Gastrointest Liver Physiol. 2017 Apr 1;312(4):G367-G373. doi: 10.1152/ajpgi.00232.2016. Epub 2017 Feb 2. Am J Physiol Gastrointest Liver Physiol. 2017. PMID: 28154011
-
Evolution of the gut microbiota and the influence of diet.Benef Microbes. 2013 Mar 1;4(1):31-7. doi: 10.3920/BM2012.0029. Benef Microbes. 2013. PMID: 23257016 Review.
-
The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases.Cell Mol Immunol. 2011 Mar;8(2):110-20. doi: 10.1038/cmi.2010.67. Epub 2011 Jan 31. Cell Mol Immunol. 2011. PMID: 21278760 Free PMC article. Review.
Cited by
-
CFP/Yit: An Inbred Mouse Strain with Slow Gastrointestinal Transit.Dig Dis Sci. 2024 Jun;69(6):2026-2043. doi: 10.1007/s10620-024-08420-x. Epub 2024 Apr 15. Dig Dis Sci. 2024. PMID: 38622463 Free PMC article.
-
Gastrointestinal Dysmotility Predisposes to Colitis through Regulation of Gut Microbial Composition and Linoleic Acid Metabolism.Adv Sci (Weinh). 2024 May;11(20):e2306297. doi: 10.1002/advs.202306297. Epub 2024 Mar 13. Adv Sci (Weinh). 2024. PMID: 38477534 Free PMC article.
-
Large intestinal nutritional and physicochemical parameters from different dog sizes reshape canine microbiota structure and functions in vitro.Bioengineered. 2024 Dec;15(1):2325713. doi: 10.1080/21655979.2024.2325713. Epub 2024 Mar 12. Bioengineered. 2024. PMID: 38471972 Free PMC article.
-
Autism spectrum disorders and the gastrointestinal tract: insights into mechanisms and clinical relevance.Nat Rev Gastroenterol Hepatol. 2024 Mar;21(3):142-163. doi: 10.1038/s41575-023-00857-1. Epub 2023 Dec 19. Nat Rev Gastroenterol Hepatol. 2024. PMID: 38114585 Review.
-
Insights into the Current and Possible Future Use of Opioid Antagonists in Relation to Opioid-Induced Constipation and Dysbiosis.Molecules. 2023 Nov 24;28(23):7766. doi: 10.3390/molecules28237766. Molecules. 2023. PMID: 38067494 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources